Related Experiment Video

Updated: Aug 7, 2026

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
04:03

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians

Published on: September 27, 2024

[Acute exacerbation of chronic obstructive pulmonary disease and antibiotics: analysis of comparative trials]

M Garré1, B Garo, S Ansart

  • 1Service de maladies infectieuses, CHU la Cavale-Blanche, boulevard Tanguy-Privent, 29609 Brest cedex, France. michel.garre@chu-brest.fr

Medecine Et Maladies Infectieuses
|July 11, 2006
PubMed
Abstract

Insights

For patients with acute exacerbations of chronic obstructive pulmonary disease (COPD), current antibiotics show no clear superiority. Shorter treatment durations appear as effective as longer ones, indicating a need for new comparative trials.

Area of Science:

  • Pulmonary Medicine
  • Infectious Diseases
  • Pharmacology

Context:

  • Acute exacerbations of chronic obstructive pulmonary disease (COPD) significantly impact patient health and healthcare costs.
  • Antibiotic therapy is a cornerstone in managing COPD exacerbations, but optimal choices and durations remain debated.

Purpose:

  • To systematically evaluate the efficacy of different antibiotics in treating acute exacerbations of COPD.
  • To compare the effectiveness of varying antibiotic treatment durations for COPD exacerbations.

Summary:

  • A systematic review of eight well-designed equivalence trials was conducted.
  • No significant differences in efficacy were observed among the antibiotics studied for COPD exacerbations.
  • Shorter antibiotic treatment regimens demonstrated comparable effectiveness to longer durations.

Impact:

  • Findings suggest that current antibiotic options may not offer superior benefits for COPD exacerbations.
  • Highlights the need for novel, high-quality comparative trials to guide antibiotic selection and treatment duration in COPD management.
  • Potential to influence clinical guidelines and reduce unnecessary antibiotic exposure, mitigating antimicrobial resistance.

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: